Insulin dysfunction and allostatic load in bipolar disorder

References

• Ketter TA. Diagnostic features, prevalence, and impact of bipolar disorder. J. Clin. Psychiatry71(6), e14 (2010).
   Google Scholar
• Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34 to 38 years. J. Affect. Disord.68(2–3), 167–181 (2002).
   PubMed Web of Science ®Google Scholar
• Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord.6(3), 224–232 (2004).
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’anna M, Yatham LN, Tramontina J et al. Emotional memory in bipolar disorder. Br. J. Psychiatry192(6), 458–463 (2008).
   PubMed Web of Science ®Google Scholar
• Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA293(20), 2528–2530 (2005).
   PubMed Web of Science ®Google Scholar
• McIntyre RS. Overview of managing medical comorbidities in patients with severe mental illness. J. Clin. Psychiatry70(6), e17 (2009).
   Google Scholar
• McIntyre RS, Soczynska JK, Beyer JL et al. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr. Opin.Psychiatry20(4), 406–416 (2007).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Danilewitz M, Liauw SS et al. Bipolar disorder and metabolic syndrome: an international perspective. J. Affect. Disord.126(3), 366–387 (2010).
   PubMed Web of Science ®Google Scholar
• Vega GL. Results of expert meetings: obesity and cardiovascular disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am. Heart J.142(6), 1108–1116 (2001).
   PubMed Web of Science ®Google Scholar
• Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr. Psychiatry Rep.11(6), 475–480 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Saiz PA, Benabarre A et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord.106(1–2), 197–201 (2008).
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Houck PR et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J. Clin. Psychiatry63(6), 528–534 (2002).
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Kupfer DJ, Houck P, Novick D, Frank E. Obesity as a correlate of outcome in bipolar I disorder. Am. J. Psychiatry160(1), 112–117 (2003).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA289(1), 76–79(2003).
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann. Clin. Psychiatry.20(3), 131–137 (2008).
   PubMed Web of Science ®Google Scholar
• Calkin C, van de Velde C, Ruzicková M et al. Can body mass index helps predict outcome in patients with bipolar disorder? Bipolar Disord.11(6), 650–656 (2009).
   PubMed Web of Science ®Google Scholar
• Gomes FA, Kauer-Sant´anna M, Magalhães PV et al. Obesity is associated with previous suicide attempts in bipolar disorder. Acta Neuropsychiatrica22, 63–67 (2010).
   PubMed Web of Science ®Google Scholar
• Kim B, Kim S, McIntyre RS, Park HJ, Kim SY, Joo YH. Correlates of abnormalities in bipolar I disorder at initiation of acute phase treatment. Psychiatry Invest.6(2), 78–84 (2009).
   PubMed Web of Science ®Google Scholar
• Ruzickova M, Slaney C, Garnham J, Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can. J. Psychiatry48(7), 458–461 (2003).
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord.7(5), 424–430 (2005).
   PubMed Web of Science ®Google Scholar
• Koponen H, Jokelainen J, Keinanen-Kiukaannieme S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J. Clin. Psychiaty69(2), 178–182 (2008).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging23(5), 921–939 (2002).
   PubMed Web of Science ®Google Scholar
• McNay EC, Cotero VE. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol. Behav.100(3), 234–238 (2010).
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Kenna HA. Insulin resistance in depressive disorders in Alzheimer’s disease: revisiting the missing link hypothesis. Neurobiol. Aging26(Suppl. 1), S103–S107 (2005).
   PubMedGoogle Scholar
• Hasselbalch S, Knudsen G, Videbaek C et al. No effect of insulin on glucose blood–brain barrier transport and cerebral metabolism. Diabetes48(10), 1915–1921 (1999).
   PubMed Web of Science ®Google Scholar
• Seaquist E, Damberg G, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes50(10), 2203–2209 (2001).
   PubMed Web of Science ®Google Scholar
• Hallschmidt M, Schultes B. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia52(11), 2264–2269 (2009).
   PubMed Web of Science ®Google Scholar
• Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci.112(5), 1199–1208 (1998).
   PubMed Web of Science ®Google Scholar
• van der Heide LP, Kamal A, Artola A, Gispen WH, Ramakers GM. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem.94(4), 1158–1166 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao W-Q, Chen H, Quon M, Alkon D. Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol.490(1–3), 71–81 (2004).
   PubMed Web of Science ®Google Scholar
• Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive avoidance task. Physiol. Behav.68(4), 509–514 (2000).
   PubMed Web of Science ®Google Scholar
• Zhao W-Q, Chen H, Xu H et al. Brain insulin receptors and spatial memory: correlated changes in gene expression, tyrosine phosphorylation, and signalling molecules in the hippocampus of water maze trained rats. J. Biol. Chem.274(49), 34893–34902 (1999).
   PubMed Web of Science ®Google Scholar
• Craft S. The role of metabolic disorder in Alzheimer disease and vascular dementia. Arch. Neurol.66(3), 300–305 (2009).
   PubMed Web of Science ®Google Scholar
• Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease. Eur. J. Pharmacol.490(1–3), 97–113 (2004).
   PubMed Web of Science ®Google Scholar
• Hong M, Lee VM. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem.272(31), 19543–19553 (1997).
   Google Scholar
• Margariños AM, McEwen BS. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl Acad. Sci. USA97(20), 11056–11061 (2000).
   PubMed Web of Science ®Google Scholar
• Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, Reagan LP. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience136(38), 477–486 (2005).
   PubMed Web of Science ®Google Scholar
• Strachan MW, Deary IJ, Ewing FM, Frier BM. Is Type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care20(3), 438–445 (1997).
   PubMed Web of Science ®Google Scholar
• Ryan CM, Geckle MO. Circumscribed cognitive dysfunction in middle-aged adults with Type 2 diabetes. Diabetes Care23(10), 1486–1493 (2000).
   PubMed Web of Science ®Google Scholar
• Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care24(6), 1060–1065 (2001).
   PubMed Web of Science ®Google Scholar
• Gold S, Dziobek I, Sweat V et al. Hippocampal damage and memory impairments as possible early brain complications of Type 2 diabetes. Diabetologia50(4), 711–719 (2007).
   PubMed Web of Science ®Google Scholar
• Bruehl H, Rueger M, Dziobek I et al. Hypothalamic–pituitary–adrenal axis dysregulation and memory impairments in Type 2 diabetes. J. Clin. Endocrinol. Metab.92(7), 2439–2445 (2007).
   PubMed Web of Science ®Google Scholar
• Yao PL, Javier D, Tsui W et al. Emotional and neutral declarative memory impairments and associated with matter microstructural abnormalities in adults with Type 2 diabetes. Psychiatry Res.174(3), 223–230 (2009).
   PubMed Web of Science ®Google Scholar
• Li L, Hölscher C. Common pathological processes in Alzheimer’s disease and Type 2 diabetes: a review. Brain. Res. Rev.56(2), 384–402 (2007).
   PubMedGoogle Scholar
• Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology63(7), 1187–1192 (2004).
   PubMed Web of Science ®Google Scholar
• Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol.3(3), 169–178 (2004).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczinska J, Konarski J et al. Should depressive syndromes be reclassified as ‘metabolic syndrome Type II’? Ann. Clin. Psychiatry19(4), 257–264 (2007).
   PubMedGoogle Scholar
• Steen E, Terry BM, Rivera EJ et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease – is this Type 3 diabetes? J. Alzheimer Dis.7(1), 63–80 (2005).
   PubMed Web of Science ®Google Scholar
• Rapp MA, Schnaider-Beeri M, Grossman HT et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry63(2), 161–167 (2006).
   PubMed Web of Science ®Google Scholar
• White MF. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab.283(3), E413–E422 (2002).
   PubMed Web of Science ®Google Scholar
• van der Heide L, Ramakers GM, Smidt M. Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol.79(4), 205–221 (2006).
   PubMed Web of Science ®Google Scholar
• Rodgers EE, Theibert AB. Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci.20(3–5), 187–197 (2002).
   PubMed Web of Science ®Google Scholar
• Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett.546(1), 108–112. 2003.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Alessi DR. The PI3K–PDK1 connection: more than just a road to PKB. Biochem. J.346(Pt 3), 561–576 (2000).
   PubMed Web of Science ®Google Scholar
• Storz P, Toker A. 3’phosphoinositide-dependent-kinase-1 (PDK-1) in PI3-kinase signaling. Front. Biosci.7, D886–D902 (2002).
   PubMed Web of Science ®Google Scholar
• Yamaguchi A, Tamatani M, Matsuzaki H et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem.276(7), 5256–5264 (2001).
   PubMed Web of Science ®Google Scholar
• Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol.11(3), 297–305 (2001).
   PubMed Web of Science ®Google Scholar
• Begum N, Ragolia L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am. J. Physiol. Cell Physiol.278(1), C81–C91 (2000).
   Google Scholar
• Reagan L. Insulin signaling effects on memory and mood. Curr. Opin. Pharmacol.7(6), 633–637 (2007).
   PubMed Web of Science ®Google Scholar
• Schmatz R, Mazzantini CM, Spanevello R et al. Resveratrol prevents memory deficits and the increase of acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol.610(1–3), 42–48 (2009).
   PubMed Web of Science ®Google Scholar
• Kroner Z. The relationship between Alzheimer’s disease and diabetes: Type 3 diabetes? Altern. Med. Rev.14(4), 373–379 (2009).
   PubMedGoogle Scholar
• Jandelai-Duhm K, Cooper M. The role of AGEs in cardiovascular disease. Curr. Pharm. Des.14(10), 979–986 (2008).
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr. Pharm. Des.14(10), 953–961 (2008).
   PubMed Web of Science ®Google Scholar
• Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Handbook of Life Stress, Cognition and Health. Fisher S, Reason J (Eds). Wiley, NY, USA, 629–649 (1988).
   Google Scholar
• McEwen BS. Stressed or stressed out: what is the difference? J. Psychiatry Neurosci.30(5), 315–318 (2005).
   PubMed Web of Science ®Google Scholar
• McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Hormon. Behav.43(1), 2–15 (2003).
   PubMed Web of Science ®Google Scholar
• Juster RP, McEwen B, Lupien S. Allostatic load biomarkers of chronic stress and impact in health and cognition. Neurosci. Biobehav. Rev.35(1), 2–16 (2010).
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathopsysiology and treatment. Neurosci. Biobehav. Rev.32(4), 675–692 (2008).
   PubMed Web of Science ®Google Scholar
• Borrel L, Crawford ND. Social disparities in periodontitis among United States adults: the effect of allostatic load. J. Epidemiol. Community Health65(2), 144–149 (2011).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin. Neurosci.8(4), 367–381 (2006).
   PubMedGoogle Scholar
• Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology30(1), 1–10 (2005).
   PubMed Web of Science ®Google Scholar
• Levine A, Zagoory-Sharon O, Feldman R, Lewis JG, Weller A. Measuring cortisol in human psychobiological studies. Physiol. Behav.90(1), 43–53 (2007).
   PubMed Web of Science ®Google Scholar
• Brown ES, Rush AJ, McEwan BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacol.21(4), 474–484 (1999).
   PubMed Web of Science ®Google Scholar
• Bruehl H, Wolf O, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-age and elderly individuals with Type 2 diabetes mellitus. Brain Res.1280, 186–194 (2009).
   PubMed Web of Science ®Google Scholar
• Vieta E, Gasto C, Martinez de Osaba MJ et al. Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test. Acta Psychiatr. Scand.95(3), 205–211 (1997).
   PubMed Web of Science ®Google Scholar
• Vieta E, Martínez De Osaba MJ, Colom F, Martínez-Arán A, Benabarre A, Gastó C. Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychol. Med.29(4), 971–978 (1999).
   PubMed Web of Science ®Google Scholar
• Watson S, Gallagher P. Hypothalamic–pituitary–adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry184, 496–502 (2004).
   PubMed Web of Science ®Google Scholar
• Daban C, Vieta E, Mackin P, Young AH. Hypothalamic–pituitary–adrenal axis and bipolar disorder. Psychiatr. Clin. North Am.28(2), 469–480 (2005).
   PubMed Web of Science ®Google Scholar
• Hunsberger J, Austin D, Chen G, Manji H. Cellular mechanisms underlying affective resilience: the role of glucocorticoid receptor and mitochondrially mediated plasticity. Brain Res.1293, 76–84 (2009).
   PubMed Web of Science ®Google Scholar
• McEwen BS, Seeman T. Protective and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load. Ann. NY Acad. Sci.896, 30–47 (1999).
   PubMed Web of Science ®Google Scholar
• Glaser R, Kiecold-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol.5(3), 243–251 (2005).
   PubMed Web of Science ®Google Scholar
• Brietzke E, Kapczinski F. TNF-α as a molecular target in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry32(6), 1355–1361 (2008).
   PubMed Web of Science ®Google Scholar
• Kishida KT, Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid. Redox Signal9(2), 233–244 (2007).
   PubMed Web of Science ®Google Scholar
• Bermejo P, Martin-Aragon S, Benedi J et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer’s disease. Immunol. Lett.117(2), 198–202 (2008).
   PubMed Web of Science ®Google Scholar
• Dugan L, Ali S, Shekhtman G, Roberts A, Lucero J, Quick K, Behrens M. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairments in aged mice through activation of neuronal NADPH oxidase. PLoS One4(5), e5518 (2009).
   PubMed Web of Science ®Google Scholar
• Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A. Biol. Sci. Med. Sci.61(6), 575–584 (2006).
   PubMed Web of Science ®Google Scholar
• Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J. Clin. Psychiatry70(8), 1078–1079 (2009).
   PubMed Web of Science ®Google Scholar
• Brietzke E, Stertz L, Fernandes BS et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord.116(3), 214–217 (2009).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism55(10 Suppl. 2), S20–S23 (2006).
   Web of Science ®Google Scholar
• Halliwell B. Oxidative stress and neurodegeneration: where are we now? J. Neurochem.97(6), 1634–1658 (2006).
   PubMed Web of Science ®Google Scholar
• Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol.72(2), 111–127 (2004).
   PubMed Web of Science ®Google Scholar
• Serrano F, Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev.3(4), 431–443 (2004).
   PubMed Web of Science ®Google Scholar
• Mir M, Tolosa L, Asensio VJ, Lladó J, Olmos G. Complementary roles of tumor necrosis factor α and interferon γ in inducible microglial nitric oxide generation. J. Neuroimmunol.204(1–2), 101–109 (2008).
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Frey BN, Kauer-Sant’anna M, Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev. Neurother.8(7), 1101–1113 (2008).
   PubMedGoogle Scholar
• Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’anna M, Cunha AB, Post R. Increased oxidative stress as a mechanism of decreased BDNF levels in acute mania. Rev. Bras. Psiquiatr.30(3), 243–245 (2008).
   PubMed Web of Science ®Google Scholar
• Kunz M, Gama CS, Andreazza AC et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatr.32(7), 1677–1681 (2008).
   PubMed Web of Science ®Google Scholar
• Seeman T, Epel E, Gruenewald T, Karlamangla A, McEwen B. Socio-economic differentials in peripheral biology: cumulative allostatic load. Ann. NY Acad. Sci.1186, 223–239 (2010).
   PubMed Web of Science ®Google Scholar
• Grunewald TL, Seeman TE, Ryff CD, Karlamangla AS, Singer BH. Combinations of biomarkers predictive of later life mortality. Proc. Natl Acad. Sci. USA103(38), 14158–14163 (2006).
   PubMed Web of Science ®Google Scholar
• Karlamangla A, Singer BH, Seeman TE. Reduction in allostatic load in older adults is associated with lower all-cause mortality risk: McArthur studies of successful aging. Psychosom. Med.68(3), 500–507 (2006).
   PubMed Web of Science ®Google Scholar
• Bauer ME, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a minireview. Neuroimmunomodulation17(3), 192–195 (2010).
   PubMed Web of Science ®Google Scholar
• McEwen BS, Wingfield JC. What is in a name? Integrating homeostasis, allostasis and stress. Hormon. Behav.57(2), 105–111 (2010).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev.87(3), 873–904 (2007).
   PubMed Web of Science ®Google Scholar
• Kaufman D, Banerji MA, Shorman I et al. Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes56(5), 1382–1386 (2007).
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Stein MB. Association between childhood trauma and physical disorders among adults in United States. Psychol. Med.34(3), 509–520 (2004).
   PubMed Web of Science ®Google Scholar
• Midei AJ, Matthews KA, Bromberger JT. Childhood abuse is associated with adiposity in midlife women: possible pathways through trait anger and reproductive hormones. Psychosom. Med.72(2), 215–223 (2010).
   PubMed Web of Science ®Google Scholar
• Karavanaki K, Tsoka E, Liacopoulou M et al. Psychological stress as a factor potentially contributing to the pathogenesis of Type 1 diabetes mellitus. J. Endocrinol. Invest.31(5), 406–415 (2008).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Alonso J, Ormel J et al. Childhood psychosocial stressors and adult onset arthritis: broad spectrum risk factors and allostatic load. Pain143(1–2), 76–83 (2009).
   PubMed Web of Science ®Google Scholar
• Thomas C, Hypponen E, Power C. Obesity and Type 2 diabetes risk in midlife: the role of childhood adversity. Pediatrics121(5), 1240–1249 (2008).
   PubMed Web of Science ®Google Scholar
• Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry49(12), 1023–1039 (2001).
   PubMed Web of Science ®Google Scholar
• Leverich GS, Post RM. Course of bipolar disorder after history of childhood trauma. Lancet367(9516), 1040–1042 (2006).
   PubMed Web of Science ®Google Scholar
• Grassi-Oliveira R, Ashy M, Stein LM. Psychobiology of childhood maltreatment: effects of allostatic load? Rev. Bras. Psiquiatr.30(1), 60–68 (2008).
   PubMed Web of Science ®Google Scholar
• Teicher MH, Samson JA, Polcari A, McGreenery CE. Sticks, stones, and hurtful words: relative effects of various forms of childhood maltreatment. Am. J. Psychiatry163(6), 993–1000 (2006).
   PubMed Web of Science ®Google Scholar
• Etain B, Henry C, Bellivier F, Mathieu F, Leboyer M. Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord.10(8), 867–876 (2008).
   PubMed Web of Science ®Google Scholar
• Lyons DM. Stress, depression, and inherited variation in primate hippocampal and prefrontal brain development. Psychopharmacol. Bull.36(1), 27–43 (2002).
   PubMedGoogle Scholar
• Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Impact of childhood abuse and clinical course of bipolar disorder. Br. J. Psychiatry186, 121–125 (2005).
   PubMed Web of Science ®Google Scholar
• McEwen B, Gianaros P. Central role of the brain in stress and adaptation: links to socioeconomic status, health and disease. Ann. NY Acad. Sci.1186, 190–222 (2010).
   PubMed Web of Science ®Google Scholar
• Alsuwaidan MT, Kucyi A, Law CW, McIntyre RS. Exercise and bipolar disorder: a review of neurobiological mediators. Neuromolecular Med.11(4), 328–336 (2009).
   PubMed Web of Science ®Google Scholar
• Kramer AF, Colcombe SJ, McAuley E et al. Enhancing brain and cognitive function of older adults through fitness training. J. Mol. Neurosci.20(3), 213–221 (2003).
   PubMed Web of Science ®Google Scholar
• Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci.25(6), 295–301 (2002).
   PubMed Web of Science ®Google Scholar
• Pajonk FG, Wobrock T, Gruber O et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch. Gen. Psychiatry67(2), 133–134 (2010).
   PubMed Web of Science ®Google Scholar
• Benedict C, Hallschmid M, Hatke A et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology29(10), 1326–1334 (2004).
   PubMed Web of Science ®Google Scholar
• Kulstad JJ, Green PS, Cook DG et al. Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease. Neurology66(10), 1506–1510 (2006).
   PubMed Web of Science ®Google Scholar
• Reger MA, Watson GS, Green PS et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma β-amyloid in memory-impaired older adults. J. Alzheimer Dis.13(3), 323–331 (2008).
   PubMed Web of Science ®Google Scholar
• Reger MA, Watson GS, Green PS et al. Intranasal insulin improves cognition and modulated β-amyloid in early AD. Neurology70(6), 440–448 (2008).
   PubMed Web of Science ®Google Scholar
• McClean P, Gault V, Harriott P, Hölscher C. Glukagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer’s disease. Eur. J. Pharmacol.630(1–3), 158–162 (2010).
   PubMed Web of Science ®Google Scholar
• Iwai T, Suzuki M, Kobayashi K, Mori K, Mogi Y, Oka JI. The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1. Neurosci. Res.64(1), 67–74 (2009).
   PubMed Web of Science ®Google Scholar
• During MJ, Cao L, Zuzga DS et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med.9(9), 1173–1179 (2003).
   PubMed Web of Science ®Google Scholar
• Liu X, Luo D, Zheng M, Hao Y, Zhang S. Effect of pioglitazone on insulin-resistance in fructose-drinking rats correlates with AGE/RAGE inhibition and block of NADPH oxidase and NFκB activation. Eur. J. Pharmacol.629(1–3), 153–158 (2010).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Lewis GF, MacQueen GM, Konarski JZ, Kennedy SH. Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opin. Pharmacother.7(10), 1305–1321 (2006).
   PubMedGoogle Scholar
• Rasgon NL, Kenna HA, Williams KE, Powers B, Wroolie T, Schatzberg AF. Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. ScientificWorldJournal10, 321–328 (2010).
   PubMedGoogle Scholar
• Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr. Res.90(1–3), 258–265 (2007).
   PubMed Web of Science ®Google Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int. J. Neuropsychopharmacol.12(4), 447–458 (2009).
   PubMed Web of Science ®Google Scholar
• Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry15(4), 384–392 (2010).
   PubMed Web of Science ®Google Scholar
• Knijff EM, Breunis MN, Kupka RW et al. An imbalance in the production of IL-1β and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord.9(7), 743–753 (2007).
   PubMed Web of Science ®Google Scholar
• Cunha AB, Andreazza AC, Gomes FA et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci.258(5), 300–304 (2008).
   PubMed Web of Science ®Google Scholar
• Maes M, Delange J, Ranjan R et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res.66(1), 1–11 (1997).
   PubMed Web of Science ®Google Scholar
• Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. Lipid levels in female patients with affective disorders. Psychiatry Res.168(3), 218–221 (2009).
   PubMed Web of Science ®Google Scholar
• Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord.10(5), 607–616 (2008).
   PubMed Web of Science ®Google Scholar
• Castilla-Puentes R. Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients. Bipolar Disord.9(7), 772–778 (2007).
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Kenna HA, Reynolds-May MF et al. Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of Type 2 diabetes mellitus. Bipolar Disord.12(5), 504–513 (2010).
   PubMed Web of Science ®Google Scholar
• Dias VV, Brissos S, Cardoso C, Andreazza AC, Kapczinski F. Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J. Affect Disord.113(3), 285–290 (2009).
   PubMed Web of Science ®Google Scholar
• Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord.11(6), 657–622 (2009).
   PubMed Web of Science ®Google Scholar